# DESCRIPTION

- introduce Mycobacterium avium paratuberculosis and antibodies
- motivate early biomarkers of type 1 diabetes
- describe Mycobacterium avium subspecies paratuberculosis transmission
- explain asymptomatic infection and humoral responses
- define type 1 diabetes and autoimmune disease
- discuss genetic and environmental factors
- motivate environmental factors in T1D pathogenesis
- describe viral infections and enteroviruses
- explain pathophysiological mechanisms of enteroviral infections
- introduce bacterial infections as T1D triggers
- describe Mycobacterium avium subspecies paratuberculosis infection
- explain environmental contamination and MAP exposure
- discuss Sardinia's high incidence of T1D and multiple sclerosis
- describe autoantibodies and epitopes related to T1D development
- introduce inventors' findings on MAP infection and T1D risk
- explain cross-reactive antibodies and molecular mimicry mechanism
- describe MAP3865c and ZnT8 proteins and their similarities
- summarize diagnostic method for T1D susceptibility
- introduce method for monitoring T1D progression
- describe use of peptides as biomarkers
- specify peptides from MAP3865c and ZnT8 sequences
- describe method for in vitro diagnosing T1D
- detail detection and quantification of antibodies
- compare values with healthy control
- specify peptides for method
- describe embodiment with four peptides
- describe embodiment with three peptides
- describe embodiment with ten peptides
- describe method using ELISA
- describe method for in vitro diagnosing T1D using lymphocytes
- specify peptides for method
- describe embodiment with four peptides
- describe embodiment with three peptides
- describe embodiment with ten peptides
- describe isolated peptides
- specify peptides from MAP3865c and ZnT8 sequences
- describe isolated nucleic acid molecules
- describe vectors and cells
- describe kit comprising peptides or nucleic acid molecules
- specify peptides for kit
- describe isolated antibodies
- describe vaccine for T1D treatment or prophylaxis
- specify peptides for vaccine
- describe embodiment with four peptides
- describe embodiment with three peptides
- describe embodiment with ten peptides
- describe anti-Mycobacterium avium paratuberculosis drugs

## EXAMPLE 1

### Study on the Cross Reactivity Between Antibodies Recognizing Mycobacterium avium Paratuberculosis Epitopes and Beta-Cell Antigen Znt8 in Type 1 Diabetes Patients

- introduce study objective
- describe patient and control serum samples
- construct pMAL-MAP3865c expression vector
- express and purify MAP3865c-MBP fusion protein
- synthesize peptides MAP3865c125-133 and MAP3865c133-141
- set up indirect enzyme-linked immunosorbent assay (ELISA)
- detect Abs specific for MAP3865c protein and peptides
- perform competition assays
- detect MAP-specific IS900 DNA in blood samples
- perform statistical analyses
- present results of anti-MAP3865c Abs prevalence
- analyze Ab reactivity against LacZ-MBP control
- determine intra-assay and inter-assay variability
- correlate anti-MAP3865c Abs with IS900 DNA positivity
- analyze aminoacid sequence homology between MAP3865c and ZnT8
- synthesize ZnT8 peptides corresponding to MAP3865c sequences
- test serum Ab reactivity against ZnT8 peptides
- compare Ab+ and Ab- negative T1D patients
- analyze correlation between Ab titers against MAP3865c and ZnT8
- perform competition experiments to verify Ab cross-reactivity
- summarize results of Ab cross-reactivity
- discuss significance of Ab cross-reactivity
- present table of T1D duration and age at T1D diagnosis
- present table of Ab reactivities against MAP3865c and ZnT8 peptides
- conclude study findings

## EXAMPLE 2

### Comparison Between the Sensitivity of ELISA Test Carried Out by Means the Epitopes of the Present Invention and Known Epitopes in the Diagnosis of T1D Onset

- introduce study objective
- describe subjects and serum samples
- synthesize peptides MAP3865c125-133, MAP3865c133-141, and others
- perform ELISA
- perform ElisaRSR ZnT8 Ab ELISA kit
- analyze Ab responses against MAP3865c and ZnT8 peptides
- present results of Ab positivity against MAP3865c and ZnT8 peptides
- discuss significance of results
- conclude study findings

## EXAMPLE 3

### Study on the Recognition of ZnT8 and MAP8635c Homologous Epitopes at T1D Onset in Sardinian Children

- introduce study objective

## ELISA

- perform ELISA and analyze results

